Evidence map›Paper›PMID 29114173›Full record

ArticleContrast media & molecular imaging2017

Stefan Sawall, Danielle Franke, Anne Kirchherr, Jan Beckendorf, Jan Kuntz, Joscha Maier, Alexander Kraupner, Johannes Backs, Andreas Briel, Marc Kachelrieß

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefan SawallMedical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.ORCID 0000-0001-8895-7541
Danielle FrankenanoPET Pharma GmbH, Luisencarrée, Robert-Koch-Platz 4, 10115 Berlin, Germany.
Anne KirchherrnanoPET Pharma GmbH, Luisencarrée, Robert-Koch-Platz 4, 10115 Berlin, Germany.
Jan BeckendorfDepartment of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.
Jan KuntzMedical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Joscha MaierMedical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Alexander KraupnernanoPET Pharma GmbH, Luisencarrée, Robert-Koch-Platz 4, 10115 Berlin, Germany.
Johannes BacksDepartment of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.
Andreas BrielnanoPET Pharma GmbH, Luisencarrée, Robert-Koch-Platz 4, 10115 Berlin, Germany.
Marc KachelrießMedical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein developed a micro-CT method using the innovative contrast agent ExiTron™ MyoC 8000 to longitudinally monitor cardiac processes

Indexed as

X-Ray MicrotomographyAnimalsContrast MediaDisease Models, AnimalDrug Evaluation, PreclinicalMiceMyocardial InfarctionContrast Media

Identifiers

PMID29114173
PMCPMC5662822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.